FDA Application
-
NDC Search Results on Active Ingredient: doxorubicin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DOXORUBICIN HYDROCHLORIDE | 45963-733-55 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0069-3031-20 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
DOXORUBICIN HYDROCHLORIDE | 68083-248-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 43598-283-35 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 70710-1531-1 | Zydus Pharmaceuticals USA Inc. | ANDA212299 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9277-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0069-3030-20 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
DOXORUBICIN HYDROCHLORIDE | 0338-0067-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA |
DOXORUBICIN HYDROCHLORIDE | 16714-856-01 | NorthStar RxLLC | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9372-01 | Hikma Pharmaceuticals USA Inc. | ANDA064097 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 67457-436-50 | Mylan Institutional LLC | ANDA200170 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9093-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9275-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 62756-827-40 | Sun Pharmaceutical Industries, Inc. | ANDA091418 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0338-9581-01 | Baxter Healthcare Corporation | HUMAN PRESCRIPTION DRUG | Unapproved drug for use in drug shortage | |
DOXORUBICIN HYDROCHLORIDE | 43598-541-25 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 62756-826-40 | Sun Pharmaceutical Industries, Inc. | ANDA091418 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9548-10 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 72603-103-01 | NorthStar RxLLC | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 70860-208-51 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9548-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 47335-050-40 | Sun Pharmaceutical Industries, Inc. | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 68001-493-26 | BluePoint Laboratories | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0143-9088-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 68083-250-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 47335-049-40 | Sun Pharmaceutical Industries, Inc. | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 0338-0086-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
DOXORUBICIN HYDROCHLORIDE | 25021-207-25 | Sagent Pharmaceuticals | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 70860-208-05 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
DOXORUBICIN HYDROCHLORIDE | 63323-101-61 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
1-30 | 31-60 | 61-78 |
-